Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Immunisation”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Testing effectiveness (Phase 2)Study completedNCT02097849
What this trial is testing

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 71
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Not applicableActive Not RecruitingNCT06906692
What this trial is testing

Meningococcal Vaccination in Patients on Complement Inhibitors

Who this might be right for
Myasthenia Gravis GeneralisedVaccinationComplement System+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Large-scale testing (Phase 3)Active Not RecruitingNCT04936685
What this trial is testing

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 209
Large-scale testing (Phase 3)Active Not RecruitingNCT06446752
What this trial is testing

BIYELA - Bexsero Immunisation in Young Women in Africa

Who this might be right for
GonorrheaGonorrhea of PharynxGonorrhea of Anus+1 more
University of Washington 1,100
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Large-scale testing (Phase 3)Study completedNCT00345579
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,432
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Testing effectiveness (Phase 2)Study completedNCT00135564
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Testing effectiveness (Phase 2)Study completedNCT02451514
What this trial is testing

Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 129
Large-scale testing (Phase 3)Study completedNCT01139021
What this trial is testing

One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age

Who this might be right for
Meningococcal Disease
Novartis Vaccines 508
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Post-approval studies (Phase 4)Study completedNCT02446691
What this trial is testing

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 128
Large-scale testing (Phase 3)Study completedNCT01266993
What this trial is testing

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 271
Testing effectiveness (Phase 2)Study completedNCT02946385
What this trial is testing

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 604
Early research (Phase 1)Ended earlyNCT04825223
What this trial is testing

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 576
Large-scale testing (Phase 3)Study completedNCT00291343
What this trial is testing

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 296
Load More Results